AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

SAB Biotherapeutics, Inc.

$3.35 -$0.42 (-11.14%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$3.23
Day Range
$3.11$3.37
Year Range
$2.44$5.15
Market Cap
304.8M
AVG Volume
586.34K
Trailing/Forward PE
0.94/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · A
020M40M60M80M20212022202320242025
SABS Revenue (USD) by year
PeriodRevenue (USD)
20250
20241.32M
20232.24M
202223.9M
202160.88M
Net Income (USD) · A
-60M-40M-20M020M20212022202320242025
SABS Net Income (USD) by year
PeriodNet Income (USD)
202513.27M
2024-34.11M
2023-42.19M
2022-18.74M
2021-17.14M
Operating Income (USD) · A
-60M-40M-20M020212022202320242025
SABS Operating Income (USD) by year
PeriodOperating Income (USD)
2025-48.95M
2024-42.91M
2023-38.08M
2022-28.92M
2021-13.39M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: SABS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

SAB Biotherapeutics, Inc.
SABS
Stockpicker

Video analysis: SABS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SABS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.